BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03401788-completion@plaintrial.com
DTSTAMP:20261028T105826Z
DTSTART;VALUE=DATE:20260329
SUMMARY:A Phase 2 Study of Belzutifan (PT2977\, MK-6482) for the Treatment 
 of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (
 MK-6482-004) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03401788
URL:https://plaintrial.com/trial/NCT03401788
END:VEVENT
END:VCALENDAR